Sourbha Dani to Cardiomyopathies
This is a "connection" page, showing publications Sourbha Dani has written about Cardiomyopathies.
Connection Strength
1.340
-
Ghoneem A, Bhatti AW, Khadke S, Mitchell J, Liu J, Zhang K, Trachtenberg B, Wechalekar A, Cheng RK, Baron SJ, Nohria A, Lenihan D, Ganatra S, Dani SS. Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure. Curr Probl Cardiol. 2023 Jun; 48(6):101667.
Score: 0.741
-
Satti DI, Choi E, Patel HP, Faisaluddin M, Mehta A, Patel B, Oyeka CP, Hegde S, Kwapong YA, Chan JSK, Anderson S, Ibrahim NE, Sinha SS, Dani SS, Sharma G. Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020). Curr Probl Cardiol. 2024 Dec; 49(12):102855.
Score: 0.207
-
Shah LM, Patel H, Faisaluddin M, Kwapong YA, Patel BA, Choi E, Satti DI, Oyeka CP, Hegde S, Dani SS, Sharma G. Rural/urban disparities in the trends and outcomes of peripartum cardiomyopathy in delivery hospitalizations. Curr Probl Cardiol. 2024 Apr; 49(4):102433.
Score: 0.198
-
Avula V, Sharma G, Kosiborod MN, Vaduganathan M, Neilan TG, Lopez T, Dent S, Baldassarre L, Scherrer-Crosbie M, Barac A, Liu J, Deswal A, Khadke S, Yang EH, Ky B, Lenihan D, Nohria A, Dani SS, Ganatra S. SGLT2 Inhibitor Use and Risk of Clinical?Events in Patients With Cancer Therapy-Related Cardiac Dysfunction. JACC Heart Fail. 2024 01; 12(1):67-78.
Score: 0.194